Background and Purpose-The pathogenesis of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage remains incompletely understood. It is generally assumed that it is caused by angiographic vasospasm. Our aim was to clarify the relationship among angiographic vasospasm, neurological worsening, cerebral infarction, and poor outcome and to investigate whether cerebral infarction also contributes to poor outcome by vasospasm-independent effects. Methods-This exploratory analysis used data from 413 patients included in the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) trial. We studied the incidence of neurological worsening, cerebral infarction, and poor outcome in patients with and without angiographic vasospasm. Path analysis implemented by structural equation modeling was performed to determine direct and indirect path coefficients. Results-Of the 194 patients with moderate to severe vasospasm, 43% had neurological worsening of any cause, 20% had cerebral infarction, and 46% poor outcome. Path coefficients for direct effects on poor outcome were 0.20 for World Federation of Neurological Surgeons Grade 4 to 5, 0.13 for history of hypertension, 0.19 for angiographic vasospasm, 0.16 for neurological worsening, and 0.11 for new cerebral infarction. Cerebral infarction contributed to poor outcome by vasospasm-dependent and -independent effects. Conclusions-Our data show that the majority of patients with moderate to severe angiographic vasospasm did not have neurological worsening of any cause or cerebral infarction. Besides, cerebral infarction also has a direct effect on outcome independent of angiographic vasospasm. This suggests that other coexisting factors might be involved in the pathogenesis of delayed cerebral ischemia, which should also be an important research target to improve outcome after subarachnoid hemorrhage. (Stroke. 2011;42:00-00.)
that in-hospital mortality from SAH has declined at 0.9% per year for the past few decades, but outcome remains poor overall. 4 Because not all patients with angiographic vasospasm have neurological deterioration, and conversely, not all patients with clinical features of DCI have angiographic vasospasm, the relationship between angiographic vasospasm on the one hand and neurological worsening and cerebral infarction on the other hand is inexact. 5 Most would accept that infarction is causally and strongly associated with poor outcome. 3, 6 The question is whether cerebral infarction can contribute to poor outcome independent of angiographic vasospasm-mediated effects.
The purpose of the present study was to clarify the relationship among angiographic vasospasm, neurological worsening, cerebral infarction, and poor outcome in a well-defined cohort of patients with SAH and to perform a path analysis to investigate which variables contribute directly and indirectly to a poor outcome after SAH.
Methods

Patients
Data were obtained from the Clazosentan to Overcome Neurological Ischemia and Infarction Occurring After Subarachnoid Hemorrhage (CONSCIOUS-1) study, which was a registered study (http://clinicaltrials.gov/ct/show/NCT00111085). 7 Methods and results of this study have been described. 7 Terms and definitions were similar to those previously used in the CONSCIOUS-1 study. 7 Angiographic vasospasm was quantified as the percent reduction in arterial diameter on digital subtraction catheter angiography obtained at baseline and 7 to 11 days after SAH using central, blinded, adjudicated assessments. A global assessment of vasospasm was made and then classified as none/mild (0% to 33%), moderate (34% to 66%), or severe (67% to 100%). In the CONSCIOUS-1 study, delayed ischemic neurological deficit (DIND) was defined as clinical worsening in combination with angiographic or transcranial Doppler evidence of vasospasm. Because DIND was supposed to be diagnosed in combination with vasospasm, this variable would result in bias in the path analysis. The path from angiographic vasospasm to DIND would be strong by definition. Therefore, we chose a variable, neurological worsening, which was defined as a decline of at least 2 points in the modified Glasgow Coma Scale 8 or an increase of at least 2 points in the abbreviated National Institutes of Health Stroke Scale 9 lasting at least 2 hours. CT scans were performed on admission within 48 hours of SAH, 24 to 48 hours after the aneurysm-securing procedure, 6 weeks after SAH, and whenever there was neurological worsening.
Causes of CT hypodensities 6 weeks after SAH were predefined, and distinction was made among the following causes: (1) vasospasm-related; (2) procedure-related; (3) intracerebral hemorrhage encephalomalacia; (4) ventricular drain encephalomalacia; (5) other; and (6) unknown. For the purpose of this study, we used the CT assessments of 1 blinded reviewer (R.L.M.). Cerebral infarction from DCI was defined as DIND-related hypodensities and hypodensities from unknown causes. Hypodensities from unknown causes were included in the definition, because DIND-related infarctions only took into account infarctions in the presence of angiographic or transcranial Doppler vasospasm. Outcome was assessed by a centrally administered telephone interview at 12 weeks measured by the extended version of the Glasgow Outcome Scale. 10 Poor outcome was defined as death, vegetative state, or severe disability. Causes of neurological worsening and death were categorized by 2 authors (M.D.I.V., R.L.M.) into the following groups: (1) primary SAH; (2) rebleeding; (3) DCI; (4) hydrocephalus; (5) procedure-related; (6) seizure and other central nervous system-related; and (7) systemic.
Analysis
First, we described the incidence of neurological worsening, cerebral infarction, poor outcome, and death in patients with and without angiographic vasospasm. ORs were calculated for patients who had angiographic vasospasm to develop neurological worsening, cerebral infarction, poor outcome, and death.
Second, to clarify the relationship between angiographic vasospasm and neurological worsening, patients were divided into 4 groups: (1) patients with both neurological worsening and moderate to severe angiographic vasospasm; (2) patients with neurological worsening but without moderate to severe angiographic vasospasm; (3) patients without neurological worsening but with moderate to severe angiographic vasospasm; and (4) patients without neurological worsening and no moderate to severe angiographic vasospasm. A prespecified imputation rule determined by the CONSCIOUS-1 steering committee was used to impute the severity of angiographic vasospasm in the 32 patients with missing digital subtraction catheter angiography data. If no digital subtraction catheter angiography was available, angiographic vasospasm was considered to be present unless it was known that the patient was alive and completed the study treatment, had no transcranial Doppler ultrasound findings or clinical symptoms of neurological worsening, and was assessed by the investigators to not have vasospasm on digital subtraction catheter angiography. Glasgow Outcome Score was assumed to be poor if it was missing.
The baseline characteristics for the 4 patient groups were described and the relationships/association of the categorical variables (gender, history of hypertension, World Federation of Neurosurgical Societies [WFNS] admission grade [1 to 5] , description of subarachnoid blood on baseline CT scan [thin local, thin diffuse, thick local, thick diffuse], intraventricular hemorrhage, intraparenchymal hemorrhage, hydrocephalus, mode of treatment [surgical clipping or coiling], and clazosentan treatment) among these patients group were compared with 2 test. Continuous variables (age, Glasgow Coma Score, Hijdra score, Graeb score, mean arterial blood pressure) were compared using independent Student t test and/or Wilcoxon rank sum test for data that were not normally distributed. The incidence of clinical complications (angiographic vasospasm, neurological worsening, new cerebral infarcts) and outcome were compared among the 4 patient groups. The continuous variables were expressed as meanϮSD and categorical variables as percentage of the group from which they were derived. We performed bivariate analyses to study the association of various baseline and clinical variables with poor outcome. The significantly associated variables (at PϽ0.10) were built into a multivariable logistic regression analysis and statistically significant predictor variables for the final model at the 5% significance level retained through backward selection of these.
Also a path analysis based on structural equation modeling was undertaken to determine the direct and indirect path coefficients for the variables angiographic vasospasm, neurological worsening, and new cerebral infarcts, which were hypothesized to have an influence on poor outcome. Path analysis uses both bivariate and multiple regression techniques to test for possible causal relationships among variables specified in the hypothesized model. 11, 12 The path coefficients are then represented on the path diagram with web-like relationships with the single-headed arrow representing the causal order between 2 variables, the head pointing to the effect and the tail the cause. The study of the correlations between the studied variables was based on polycoric correlation instead of Pearson correlation because most of the interest variables were binary. We adjusted the path model for the baseline factors (history of hypertension and WFNS grade) that were associated with outcome.
Results
Baseline characteristics of all patients are described in Supplemental Table I (available at http://stroke.ahajournals.org). The relationship among angiographic vasospasm, neurological worsening, cerebral infarction, and outcome is illustrated in Figure 1 . In the total group of 413 patients, 194 patients (47%) developed moderate to severe vasospasm, 114 patients (34%) had neurological worsening, 45 patients (11%) had cerebral infarction, 125 patients (30%) had a poor outcome, and 25 patients (6%) died. Causes of neurological deterioration and death are described in Patients were divided into 4 groups based on whether they developed angiographic vasospasm and neurological worsening. Baseline characteristics of the 4 groups are shown in Supplemental Table I. In total, 83 patients (20%) had moderate to severe vasospasm on angiography in combination with neurological worsening, 111 patients (27%) had moderate to severe vasospasm without neurological worsening, 31 patients (8%) had no or mild vasospasm in combination with neurological worsening, and 188 patients (46%) had no or mild vasospasm and no neurological worsening. Significant differences between groups were observed for Glasgow Coma Score on admission (Pϭ0.0002), WFNS admission grade (PϽ0.0001), incidence of thick clot size (Pϭ0.01), Hijdra score on admission CT scan (PϽ0.0001), amount of intraventricular (Pϭ0.003) and intraparenchymal blood (PϽ0.0001), type of aneurysm treatment (Pϭ0.007), and treatment with clazosentan (PϽ0.0001).
Cerebral infarction on CT was most common in patients with vasospasm and neurological worsening (31%), fairly common in patients with either vasospasm and no neurological worsening or no vasospasm with neurological worsening (14% and 16%, respectively), and rare in patients with no vasospasm or neurological worsening (3%; PϽ0.0001). Poor outcome also followed the same pattern. It was most common in patients with vasospasm and neurological worsening (60%), fairly common in patients with either vasospasm and no neurological worsening or no vasospasm with neurological worsening (35% and 36%, respectively), and less common in patients with no vasospasm or neurological worsening (13%).
Results of uni-and multivariate analyses are shown in The hypotheses that angiographic vasospasm, neurological worsening, new cerebral infarcts, WFNS grade (4 to 5), and history of hypertension influenced poor outcome measured by the extended version of the Glasgow Outcome Scale 12 weeks after SAH were further tested with path analysis. The results with both the direct and indirect path coefficients are (17) 4 (16) depicted on the path diagram ( Figure 2 ). Poor outcome was the dependent variable. Exogenous independent variables were WFNS grade and history of hypertension. Endogenous independent variables were angiographic vasospasm, neurological worsening, and new cerebral infarcts. Multicollinearity was not found to be a problem because the bivariate correlations did not exceed 0.70. The path coefficients (direct and indirect) of the studied variables on poor outcome revealed the sizes of the correlations between these variables and suggest that all of the variables (angiographic vasospasm, neurological worsening, new cerebral infarcts, WFNS Grade 4 to 5, and history of hypertension) significantly and directly affect poor outcome (Figure 2 ). Poor WFNS grade also is independently associated with an increased risk of angiographic vasospasm, neurological worsening, and cerebral infarction. Angiographic vasospasm independently led to neurological worsening and, probably in patients who could not be assessed neurologically, cerebral infarction without neurological worsening.
Discussion
The results of the present study yield important data on the relationship among angiographic vasospasm, neurological worsening, cerebral infarction, and poor outcome after SAH. Although angiographic vasospasm was strongly associated with neurological worsening, cerebral infarction, and poor outcome, it was also shown that only 43% of the patients with vasospasm developed neurological worsening of any cause, and 20% had new cerebral infarction on follow-up imaging. The path analysis showed that the only potentially modifiable variables that affect outcome after SAH are angiographic vasospasm, neurological worsening, and new cerebral infarction. Interestingly, path analysis suggests cerebral infarction contributes to poor outcome by both vasospasm-dependent and -independent effects. The results of this study confirm the strong association between angiographic vasospasm on the 1 hand and DCI/ cerebral infarction, 3, 6, 13 poor outcome, 14 and mortality 15 on the other. However, despite its undisputed associations, there has been debate if this association implies causality. 16, 17 For example, DCI may occur in the absence of angiographic vasospasm. 5, 18 Also, a recent double-blind, placebo-controlled Phase 2 study investigating the effect of the endothelin receptor antagonist clazosentan in patients with aneurysmal SAH showed a 65% relative risk reduction (95% CI, 47% to 78%) of angiographic vasospasm in the group of patients that received the highest dose of clazosentan (15 mg/h), although no effect on the extended version of the Figure 2 . Path analysis of variables contributing to poor outcome after SAH with direct and indirect path coefficients.
Glasgow Outcome Scale was observed. 7 This does not rule out causality because the trial was not powered to detect an effect on the dichotomous extended version of the Glasgow Outcome Scale. It also does not exclude the possibility that adverse events in the treated patients such as hypotension or pulmonary complications associated with positive fluid balance counterbalanced the beneficial effect of reducing angiographic vasospasm. Besides, vasospasm is more prevalent in patients with poor-grade SAH, which is a prognostic factor of poor outcome itself.
What do the present data teach us about the relationship between angiographic vasospasm, neurological worsening, cerebral infarction, and poor outcome? First, 57% of patients with moderate to severe angiographic vasospasm did not have neurological deterioration of any cause. This could be because besides angiographic vasospasm, other coexisting mechanisms may contribute to whether a patient develops DCI. Another possibility is that angiographic vasospasm was not severe enough in some cases to reduce cerebral blood flow. This has often been attributed to a good collateral blood supply, but evidence to support this is difficult to identify. The additional mechanisms contributing to DCI that have been suggested include microthromboembolism, cortical spreading ischemia, spasm in the microcirculation, and impaired cerebral autoregulation. 17,19 -21 The same arguments about association versus causality bear on these additional hypotheses, especially given the failure of treatments targeted at them to reduce poor outcome. 22 This analysis also showed that cerebral infarction mostly occurred in patients who developed angiographic vasospasm, which on first sight suggests that the development of cerebral infarction after SAH is almost always vasospasm-dependent. However, the path analysis showed that cerebral infarction may develop independent of vasospasm. This finding again suggests that mechanisms other than vasospasm have an important function in the pathogenesis of cerebral infarction after SAH. The path analysis also showed that the main independent determinants of poor outcome after SAH are a history of hypertension, female gender, WFNS Grade 4 to 5, angiographic vasospasm, neurological worsening of any cause, and cerebral infarction. Of these variables, only angiographic vasospasm, neurological deterioration, and cerebral infarction are potentially modifiable. Therefore, future research aiming to reduce poor outcome after SAH should focus on these 3 variables.
This study has several limitations. First, one could argue that it would have been better to use DIND instead of neurological worsening of any cause. We used neurological worsening because the clinical diagnosis of DCI is quite difficult and mostly a diagnosis of exclusion that probably has high interobserver variation. Using neurological worsening of any cause instead of DIND increased the sensitivity to detect DCI. Another important reason for not using DIND was that the CONSCIOUS-1 study defined DIND in evaluable patients as locally defined vasospasm on digital subtraction catheter angiography or transcranial Doppler associated with neurological worsening lasting for at least 2 hours. Thus, patients with DCI in the absence of angiographic vasospasm would be missed. Second, a path analysis does not show causal relationships. Third, this was a post hoc analysis of data from a randomized controlled trial. Because of inclusion and exclusion criteria of the original trial, our results may not be generalizable to all patients with SAH. For example, in CONSCIOUS-1, only 1% of the patients had a WFNS score of 5 on admission. Therefore, case fatality was only 6%, whereas in other studies, it has been shown to be approximately 30%. 4 Infarction rate in our study was only 11%, which could be an underestimation or also a reflection of including less severely affected patients with SAH.
In conclusion, less than half of the patients with angiographic vasospasm had neurological worsening of any cause, and one fifth had cerebral infarction. This suggests that other coexisting factors might be involved in the pathogenesis of DCI. Because cerebral infarction also had a direct effect on outcome independent of angiographic vasospasm, cerebral infarction per se should also be an important research target to improve outcome after SAH.
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